Index
1 Market Overview of Cell Viability Assays
1.1 Cell Viability Assays Market Overview
1.1.1 Cell Viability Assays Product Scope
1.1.2 Cell Viability Assays Market Status and Outlook
1.2 Global Cell Viability Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell Viability Assays Market Size by Region (2018-2029)
1.4 Global Cell Viability Assays Historic Market Size by Region (2018-2023)
1.5 Global Cell Viability Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell Viability Assays Market Size (2018-2029)
1.6.1 North America Cell Viability Assays Market Size (2018-2029)
1.6.2 Europe Cell Viability Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Cell Viability Assays Market Size (2018-2029)
1.6.4 Latin America Cell Viability Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Cell Viability Assays Market Size (2018-2029)
2 Cell Viability Assays Market by Type
2.1 Introduction
2.1.1 Human Cells
2.1.2 Microbial Cells
2.1.3 Animal Cells
2.2 Global Cell Viability Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell Viability Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Viability Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell Viability Assays Revenue Breakdown by Type (2018-2029)
3 Cell Viability Assays Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biotechnology Companies
3.1.2 Academic and Research Institutes
3.1.3 Hospital and Diagnostic Laboratories
3.1.4 Others
3.2 Global Cell Viability Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell Viability Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Viability Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell Viability Assays Revenue Breakdown by Application (2018-2029)
4 Cell Viability Assays Competition Analysis by Players
4.1 Global Cell Viability Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
4.3 Date of Key Players Enter into Cell Viability Assays Market
4.4 Global Top Players Cell Viability Assays Headquarters and Area Served
4.5 Key Players Cell Viability Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Viability Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Cell Viability Assays Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Cell Viability Assays Products, Services and Solutions
5.2.4 Merck Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Bio-Rad
5.3.1 Bio-Rad Profile
5.3.2 Bio-Rad Main Business
5.3.3 Bio-Rad Cell Viability Assays Products, Services and Solutions
5.3.4 Bio-Rad Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.3.5 GE Recent Developments
5.4 GE
5.4.1 GE Profile
5.4.2 GE Main Business
5.4.3 GE Cell Viability Assays Products, Services and Solutions
5.4.4 GE Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.4.5 GE Recent Developments
5.5 Danaher
5.5.1 Danaher Profile
5.5.2 Danaher Main Business
5.5.3 Danaher Cell Viability Assays Products, Services and Solutions
5.5.4 Danaher Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Cell Viability Assays Products, Services and Solutions
5.6.4 BD Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 PerkinElmer
5.7.1 PerkinElmer Profile
5.7.2 PerkinElmer Main Business
5.7.3 PerkinElmer Cell Viability Assays Products, Services and Solutions
5.7.4 PerkinElmer Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.7.5 PerkinElmer Recent Developments
5.8 Promega
5.8.1 Promega Profile
5.8.2 Promega Main Business
5.8.3 Promega Cell Viability Assays Products, Services and Solutions
5.8.4 Promega Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Promega Recent Developments
5.9 Biotium
5.9.1 Biotium Profile
5.9.2 Biotium Main Business
5.9.3 Biotium Cell Viability Assays Products, Services and Solutions
5.9.4 Biotium Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Biotium Recent Developments
5.10 Abcam
5.10.1 Abcam Profile
5.10.2 Abcam Main Business
5.10.3 Abcam Cell Viability Assays Products, Services and Solutions
5.10.4 Abcam Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Abcam Recent Developments
5.11 Creative Bioarray
5.11.1 Creative Bioarray Profile
5.11.2 Creative Bioarray Main Business
5.11.3 Creative Bioarray Cell Viability Assays Products, Services and Solutions
5.11.4 Creative Bioarray Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Creative Bioarray Recent Developments
5.12 Biotek Instruments
5.12.1 Biotek Instruments Profile
5.12.2 Biotek Instruments Main Business
5.12.3 Biotek Instruments Cell Viability Assays Products, Services and Solutions
5.12.4 Biotek Instruments Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.12.5 Biotek Instruments Recent Developments
6 North America
6.1 North America Cell Viability Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell Viability Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Viability Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Viability Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Viability Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Viability Assays Market Dynamics
11.1 Cell Viability Assays Industry Trends
11.2 Cell Viability Assays Market Drivers
11.3 Cell Viability Assays Market Challenges
11.4 Cell Viability Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List